[
  {
    "inputSequence": {
      "header": "unk",
      "SHA512": "2b569c872c9be5f1d05f498efe17ee327df6a507a089e3c92411792f293d590c744d9bcc3c8bcc82c297241ef7abdc89bc929d3ab769f67e3e9d706713d7dc8e"
    },
    "subtypeText": "B (2.55%)",
    "validationResults": [],
    "alignedGeneSequences": [
      {
        "firstAA": 1,
        "lastAA": 288,
        "gene": {
          "name": "RT",
          "length": 560
        },
        "mutations": [
          {
            "consensus": "T",
            "position": 27,
            "AAs": "S",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "E",
            "position": 28,
            "AAs": "K",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "K",
            "position": 32,
            "AAs": "E",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "V",
            "position": 60,
            "AAs": "I",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "T",
            "position": 69,
            "AAs": "N",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "R",
            "position": 83,
            "AAs": "K",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "K",
            "position": 101,
            "AAs": "E",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "Y",
            "position": 181,
            "AAs": "CFGV",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "G",
            "position": 190,
            "AAs": "AG",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "T",
            "position": 200,
            "AAs": "A",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "Q",
            "position": 207,
            "AAs": "D",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "L",
            "position": 228,
            "AAs": "R",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "V",
            "position": 245,
            "AAs": "E",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "K",
            "position": 281,
            "AAs": "EK",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          },
          {
            "consensus": "T",
            "position": 286,
            "AAs": "A",
            "isInsertion": false,
            "isDeletion": false,
            "isApobecDRM": false
          }
        ],
        "SDRMs": [
          {
            "text": "K101E"
          },
          {
            "text": "Y181CV"
          },
          {
            "text": "G190A"
          }
        ],
        "alignedNAs": "CCCATTAGTCCTATTGAAACTGTACCAGTAAAATTAAAGCCAGGAATGGATGGCCCAAAAGTTAAACAATGGCCATTGTCAAAAGAAAAAATAGAAGCATTAGTAGAAATTTGTACAGAAATGGAAAAGGAAGGAAAAATTTCAAAAATTGGGCCTGAAAATCCATACAATACTCCAATATTTGCCATAAAGAAAAAAGACAGTAATAAATGGAGAAAGTTAGTAGATTTCAGGGAACTTAATAAGAAAACTCAAGACTTCTGGGAAGTTCAATTAGGAATACCACATCCTGCAGGGTTAGAAAAGAAAAAATCAGTAACAGTACTGGATGTGGGTGATGCATATTTTTCAGTTCCCTTAGATAAAGACTTCAGGAAGTATACTGCATTTACCATACCTAGTATAAACAATGAGACACCAGGGATTAGATATCAGTACAATGTGCTTCCACAGGGATGGAAAGGATCACCAGCAATATTTCAAAGTAGCATGACAAAAATCTTAGAGCCTTTTAGAAAACAAAATCCAGACATAGTTATCKKTCAATACATGGATGATTTGTATGTAGSATCTGACTTAGAAATAGGGCAGCATAGAGCAAAAATAGAGGAACTGAGAGATCATTTGTTAAGGTGGGGATTTACCACACCAGACAAAAAACATCAGAAAGAACCTCCATTCCGTTGGATGGGTTATGAACTCCATCCTGACAAATGGACAGTACAGCCTATAGARCTGCCAGAAAAGGACAGCTGGACTGTCAATGACATACAGAAGTTAGTAGGAAAATTAAATTGGGCAAGTCAGATTTATGCAGGGATTAAAGTAAAACAATTATGTRAACTCCTTAGGGGAGCCAAAGCA",
        "alignedAAs": "PISPIETVPVKLKPGMDGPKVKQWPLSKEKIEALVEICTEMEKEGKISKIGPENPYNTPIFAIKKKDSNKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLEKKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIXQYMDDLYVASDLEIGQHRAKIEELRDHLLRWGFTTPDKKHQKEPPFRWMGYELHPDKWTVQPIELPEKDSWTVNDIQKLVGKLNWASQIYAGIKVKQLCELLRGAKA",
        "prettyPairwise": {
          "positionLine": [
            " 1 ",
            " 2 ",
            " 3 ",
            " 4 ",
            " 5 ",
            " 6 ",
            " 7 ",
            " 8 ",
            " 9 ",
            "10 ",
            "11 ",
            "12 ",
            "13 ",
            "14 ",
            "15 ",
            "16 ",
            "17 ",
            "18 ",
            "19 ",
            "20 ",
            "21 ",
            "22 ",
            "23 ",
            "24 ",
            "25 ",
            "26 ",
            "27 ",
            "28 ",
            "29 ",
            "30 ",
            "31 ",
            "32 ",
            "33 ",
            "34 ",
            "35 ",
            "36 ",
            "37 ",
            "38 ",
            "39 ",
            "40 ",
            "41 ",
            "42 ",
            "43 ",
            "44 ",
            "45 ",
            "46 ",
            "47 ",
            "48 ",
            "49 ",
            "50 ",
            "51 ",
            "52 ",
            "53 ",
            "54 ",
            "55 ",
            "56 ",
            "57 ",
            "58 ",
            "59 ",
            "60 ",
            "61 ",
            "62 ",
            "63 ",
            "64 ",
            "65 ",
            "66 ",
            "67 ",
            "68 ",
            "69 ",
            "70 ",
            "71 ",
            "72 ",
            "73 ",
            "74 ",
            "75 ",
            "76 ",
            "77 ",
            "78 ",
            "79 ",
            "80 ",
            "81 ",
            "82 ",
            "83 ",
            "84 ",
            "85 ",
            "86 ",
            "87 ",
            "88 ",
            "89 ",
            "90 ",
            "91 ",
            "92 ",
            "93 ",
            "94 ",
            "95 ",
            "96 ",
            "97 ",
            "98 ",
            "99 ",
            "100",
            "101",
            "102",
            "103",
            "104",
            "105",
            "106",
            "107",
            "108",
            "109",
            "110",
            "111",
            "112",
            "113",
            "114",
            "115",
            "116",
            "117",
            "118",
            "119",
            "120",
            "121",
            "122",
            "123",
            "124",
            "125",
            "126",
            "127",
            "128",
            "129",
            "130",
            "131",
            "132",
            "133",
            "134",
            "135",
            "136",
            "137",
            "138",
            "139",
            "140",
            "141",
            "142",
            "143",
            "144",
            "145",
            "146",
            "147",
            "148",
            "149",
            "150",
            "151",
            "152",
            "153",
            "154",
            "155",
            "156",
            "157",
            "158",
            "159",
            "160",
            "161",
            "162",
            "163",
            "164",
            "165",
            "166",
            "167",
            "168",
            "169",
            "170",
            "171",
            "172",
            "173",
            "174",
            "175",
            "176",
            "177",
            "178",
            "179",
            "180",
            "181",
            "182",
            "183",
            "184",
            "185",
            "186",
            "187",
            "188",
            "189",
            "190",
            "191",
            "192",
            "193",
            "194",
            "195",
            "196",
            "197",
            "198",
            "199",
            "200",
            "201",
            "202",
            "203",
            "204",
            "205",
            "206",
            "207",
            "208",
            "209",
            "210",
            "211",
            "212",
            "213",
            "214",
            "215",
            "216",
            "217",
            "218",
            "219",
            "220",
            "221",
            "222",
            "223",
            "224",
            "225",
            "226",
            "227",
            "228",
            "229",
            "230",
            "231",
            "232",
            "233",
            "234",
            "235",
            "236",
            "237",
            "238",
            "239",
            "240",
            "241",
            "242",
            "243",
            "244",
            "245",
            "246",
            "247",
            "248",
            "249",
            "250",
            "251",
            "252",
            "253",
            "254",
            "255",
            "256",
            "257",
            "258",
            "259",
            "260",
            "261",
            "262",
            "263",
            "264",
            "265",
            "266",
            "267",
            "268",
            "269",
            "270",
            "271",
            "272",
            "273",
            "274",
            "275",
            "276",
            "277",
            "278",
            "279",
            "280",
            "281",
            "282",
            "283",
            "284",
            "285",
            "286",
            "287",
            "288"
          ],
          "refAALine": [
            " P ",
            " I ",
            " S ",
            " P ",
            " I ",
            " E ",
            " T ",
            " V ",
            " P ",
            " V ",
            " K ",
            " L ",
            " K ",
            " P ",
            " G ",
            " M ",
            " D ",
            " G ",
            " P ",
            " K ",
            " V ",
            " K ",
            " Q ",
            " W ",
            " P ",
            " L ",
            " T ",
            " E ",
            " E ",
            " K ",
            " I ",
            " K ",
            " A ",
            " L ",
            " V ",
            " E ",
            " I ",
            " C ",
            " T ",
            " E ",
            " M ",
            " E ",
            " K ",
            " E ",
            " G ",
            " K ",
            " I ",
            " S ",
            " K ",
            " I ",
            " G ",
            " P ",
            " E ",
            " N ",
            " P ",
            " Y ",
            " N ",
            " T ",
            " P ",
            " V ",
            " F ",
            " A ",
            " I ",
            " K ",
            " K ",
            " K ",
            " D ",
            " S ",
            " T ",
            " K ",
            " W ",
            " R ",
            " K ",
            " L ",
            " V ",
            " D ",
            " F ",
            " R ",
            " E ",
            " L ",
            " N ",
            " K ",
            " R ",
            " T ",
            " Q ",
            " D ",
            " F ",
            " W ",
            " E ",
            " V ",
            " Q ",
            " L ",
            " G ",
            " I ",
            " P ",
            " H ",
            " P ",
            " A ",
            " G ",
            " L ",
            " K ",
            " K ",
            " K ",
            " K ",
            " S ",
            " V ",
            " T ",
            " V ",
            " L ",
            " D ",
            " V ",
            " G ",
            " D ",
            " A ",
            " Y ",
            " F ",
            " S ",
            " V ",
            " P ",
            " L ",
            " D ",
            " K ",
            " D ",
            " F ",
            " R ",
            " K ",
            " Y ",
            " T ",
            " A ",
            " F ",
            " T ",
            " I ",
            " P ",
            " S ",
            " I ",
            " N ",
            " N ",
            " E ",
            " T ",
            " P ",
            " G ",
            " I ",
            " R ",
            " Y ",
            " Q ",
            " Y ",
            " N ",
            " V ",
            " L ",
            " P ",
            " Q ",
            " G ",
            " W ",
            " K ",
            " G ",
            " S ",
            " P ",
            " A ",
            " I ",
            " F ",
            " Q ",
            " S ",
            " S ",
            " M ",
            " T ",
            " K ",
            " I ",
            " L ",
            " E ",
            " P ",
            " F ",
            " R ",
            " K ",
            " Q ",
            " N ",
            " P ",
            " D ",
            " I ",
            " V ",
            " I ",
            " Y ",
            " Q ",
            " Y ",
            " M ",
            " D ",
            " D ",
            " L ",
            " Y ",
            " V ",
            " G ",
            " S ",
            " D ",
            " L ",
            " E ",
            " I ",
            " G ",
            " Q ",
            " H ",
            " R ",
            " T ",
            " K ",
            " I ",
            " E ",
            " E ",
            " L ",
            " R ",
            " Q ",
            " H ",
            " L ",
            " L ",
            " R ",
            " W ",
            " G ",
            " F ",
            " T ",
            " T ",
            " P ",
            " D ",
            " K ",
            " K ",
            " H ",
            " Q ",
            " K ",
            " E ",
            " P ",
            " P ",
            " F ",
            " L ",
            " W ",
            " M ",
            " G ",
            " Y ",
            " E ",
            " L ",
            " H ",
            " P ",
            " D ",
            " K ",
            " W ",
            " T ",
            " V ",
            " Q ",
            " P ",
            " I ",
            " V ",
            " L ",
            " P ",
            " E ",
            " K ",
            " D ",
            " S ",
            " W ",
            " T ",
            " V ",
            " N ",
            " D ",
            " I ",
            " Q ",
            " K ",
            " L ",
            " V ",
            " G ",
            " K ",
            " L ",
            " N ",
            " W ",
            " A ",
            " S ",
            " Q ",
            " I ",
            " Y ",
            " A ",
            " G ",
            " I ",
            " K ",
            " V ",
            " K ",
            " Q ",
            " L ",
            " C ",
            " K ",
            " L ",
            " L ",
            " R ",
            " G ",
            " T ",
            " K ",
            " A "
          ],
          "alignedNAsLine": [
            "CCC",
            "ATT",
            "AGT",
            "CCT",
            "ATT",
            "GAA",
            "ACT",
            "GTA",
            "CCA",
            "GTA",
            "AAA",
            "TTA",
            "AAG",
            "CCA",
            "GGA",
            "ATG",
            "GAT",
            "GGC",
            "CCA",
            "AAA",
            "GTT",
            "AAA",
            "CAA",
            "TGG",
            "CCA",
            "TTG",
            "TCA",
            "AAA",
            "GAA",
            "AAA",
            "ATA",
            "GAA",
            "GCA",
            "TTA",
            "GTA",
            "GAA",
            "ATT",
            "TGT",
            "ACA",
            "GAA",
            "ATG",
            "GAA",
            "AAG",
            "GAA",
            "GGA",
            "AAA",
            "ATT",
            "TCA",
            "AAA",
            "ATT",
            "GGG",
            "CCT",
            "GAA",
            "AAT",
            "CCA",
            "TAC",
            "AAT",
            "ACT",
            "CCA",
            "ATA",
            "TTT",
            "GCC",
            "ATA",
            "AAG",
            "AAA",
            "AAA",
            "GAC",
            "AGT",
            "AAT",
            "AAA",
            "TGG",
            "AGA",
            "AAG",
            "TTA",
            "GTA",
            "GAT",
            "TTC",
            "AGG",
            "GAA",
            "CTT",
            "AAT",
            "AAG",
            "AAA",
            "ACT",
            "CAA",
            "GAC",
            "TTC",
            "TGG",
            "GAA",
            "GTT",
            "CAA",
            "TTA",
            "GGA",
            "ATA",
            "CCA",
            "CAT",
            "CCT",
            "GCA",
            "GGG",
            "TTA",
            "GAA",
            "AAG",
            "AAA",
            "AAA",
            "TCA",
            "GTA",
            "ACA",
            "GTA",
            "CTG",
            "GAT",
            "GTG",
            "GGT",
            "GAT",
            "GCA",
            "TAT",
            "TTT",
            "TCA",
            "GTT",
            "CCC",
            "TTA",
            "GAT",
            "AAA",
            "GAC",
            "TTC",
            "AGG",
            "AAG",
            "TAT",
            "ACT",
            "GCA",
            "TTT",
            "ACC",
            "ATA",
            "CCT",
            "AGT",
            "ATA",
            "AAC",
            "AAT",
            "GAG",
            "ACA",
            "CCA",
            "GGG",
            "ATT",
            "AGA",
            "TAT",
            "CAG",
            "TAC",
            "AAT",
            "GTG",
            "CTT",
            "CCA",
            "CAG",
            "GGA",
            "TGG",
            "AAA",
            "GGA",
            "TCA",
            "CCA",
            "GCA",
            "ATA",
            "TTT",
            "CAA",
            "AGT",
            "AGC",
            "ATG",
            "ACA",
            "AAA",
            "ATC",
            "TTA",
            "GAG",
            "CCT",
            "TTT",
            "AGA",
            "AAA",
            "CAA",
            "AAT",
            "CCA",
            "GAC",
            "ATA",
            "GTT",
            "ATC",
            "KKT",
            "CAA",
            "TAC",
            "ATG",
            "GAT",
            "GAT",
            "TTG",
            "TAT",
            "GTA",
            "GSA",
            "TCT",
            "GAC",
            "TTA",
            "GAA",
            "ATA",
            "GGG",
            "CAG",
            "CAT",
            "AGA",
            "GCA",
            "AAA",
            "ATA",
            "GAG",
            "GAA",
            "CTG",
            "AGA",
            "GAT",
            "CAT",
            "TTG",
            "TTA",
            "AGG",
            "TGG",
            "GGA",
            "TTT",
            "ACC",
            "ACA",
            "CCA",
            "GAC",
            "AAA",
            "AAA",
            "CAT",
            "CAG",
            "AAA",
            "GAA",
            "CCT",
            "CCA",
            "TTC",
            "CGT",
            "TGG",
            "ATG",
            "GGT",
            "TAT",
            "GAA",
            "CTC",
            "CAT",
            "CCT",
            "GAC",
            "AAA",
            "TGG",
            "ACA",
            "GTA",
            "CAG",
            "CCT",
            "ATA",
            "GAR",
            "CTG",
            "CCA",
            "GAA",
            "AAG",
            "GAC",
            "AGC",
            "TGG",
            "ACT",
            "GTC",
            "AAT",
            "GAC",
            "ATA",
            "CAG",
            "AAG",
            "TTA",
            "GTA",
            "GGA",
            "AAA",
            "TTA",
            "AAT",
            "TGG",
            "GCA",
            "AGT",
            "CAG",
            "ATT",
            "TAT",
            "GCA",
            "GGG",
            "ATT",
            "AAA",
            "GTA",
            "AAA",
            "CAA",
            "TTA",
            "TGT",
            "RAA",
            "CTC",
            "CTT",
            "AGG",
            "GGA",
            "GCC",
            "AAA",
            "GCA"
          ],
          "mutationLine": [
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " S ",
            " K ",
            " - ",
            " - ",
            " - ",
            " E ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " I ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " N ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " K ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " E ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            "CFGV",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            "GA ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " A ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " D ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " R ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " E ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            " - ",
            "KE ",
            " - ",
            " - ",
            " - ",
            " - ",
            " A ",
            " - ",
            " - "
          ]
        }
      }
    ],
    "drugResistance": [
      {
        "version": {
          "text": "8.8",
          "publishDate": "2019-02-13"
        },
        "gene": {
          "name": "RT"
        },
        "drugScores": [
          {
            "drugClass": {
              "name": "NRTI"
            },
            "drug": {
              "name": "ABC",
              "displayAbbr": "ABC"
            },
            "score": 0.0,
            "partialScores": [],
            "text": "Susceptible"
          },
          {
            "drugClass": {
              "name": "NRTI"
            },
            "drug": {
              "name": "AZT",
              "displayAbbr": "AZT"
            },
            "score": 0.0,
            "partialScores": [],
            "text": "Susceptible"
          },
          {
            "drugClass": {
              "name": "NRTI"
            },
            "drug": {
              "name": "D4T",
              "displayAbbr": "D4T"
            },
            "score": 0.0,
            "partialScores": [],
            "text": "Susceptible"
          },
          {
            "drugClass": {
              "name": "NRTI"
            },
            "drug": {
              "name": "DDI",
              "displayAbbr": "DDI"
            },
            "score": 0.0,
            "partialScores": [],
            "text": "Susceptible"
          },
          {
            "drugClass": {
              "name": "NRTI"
            },
            "drug": {
              "name": "FTC",
              "displayAbbr": "FTC"
            },
            "score": 0.0,
            "partialScores": [],
            "text": "Susceptible"
          },
          {
            "drugClass": {
              "name": "NRTI"
            },
            "drug": {
              "name": "LMV",
              "displayAbbr": "3TC"
            },
            "score": 0.0,
            "partialScores": [],
            "text": "Susceptible"
          },
          {
            "drugClass": {
              "name": "NRTI"
            },
            "drug": {
              "name": "TDF",
              "displayAbbr": "TDF"
            },
            "score": 0.0,
            "partialScores": [],
            "text": "Susceptible"
          },
          {
            "drugClass": {
              "name": "NNRTI"
            },
            "drug": {
              "name": "DOR",
              "displayAbbr": "DOR"
            },
            "score": 60.0,
            "partialScores": [
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 15.0
              },
              {
                "mutations": [
                  {
                    "text": "Y181V",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181I/V are 2-base pair non-polymorphic mutations selected by NVP and ETR. They cause high-level resistance to NVP, ETR, and RPV. They each have a weight of 3.0 in the Tibotec ETR genotypic susceptibility score. Their effects on DOR have not been well-characterized."
                      }
                    ]
                  }
                ],
                "score": 20.0
              },
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  },
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 5.0
              },
              {
                "mutations": [
                  {
                    "text": "Y181C",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
                      }
                    ]
                  },
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 20.0
              }
            ],
            "text": "High-Level Resistance"
          },
          {
            "drugClass": {
              "name": "NNRTI"
            },
            "drug": {
              "name": "EFV",
              "displayAbbr": "EFV"
            },
            "score": 95.0,
            "partialScores": [
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 15.0
              },
              {
                "mutations": [
                  {
                    "text": "Y181C",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 30.0
              },
              {
                "mutations": [
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 45.0
              },
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  },
                  {
                    "text": "Y181C",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 5.0
              }
            ],
            "text": "High-Level Resistance"
          },
          {
            "drugClass": {
              "name": "NNRTI"
            },
            "drug": {
              "name": "ETR",
              "displayAbbr": "ETR"
            },
            "score": 105.0,
            "partialScores": [
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 15.0
              },
              {
                "mutations": [
                  {
                    "text": "Y181V",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181I/V are 2-base pair non-polymorphic mutations selected by NVP and ETR. They cause high-level resistance to NVP, ETR, and RPV. They each have a weight of 3.0 in the Tibotec ETR genotypic susceptibility score. Their effects on DOR have not been well-characterized."
                      }
                    ]
                  }
                ],
                "score": 60.0
              },
              {
                "mutations": [
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 10.0
              },
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  },
                  {
                    "text": "Y181C",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 5.0
              },
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  },
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 5.0
              },
              {
                "mutations": [
                  {
                    "text": "Y181C",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
                      }
                    ]
                  },
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 10.0
              }
            ],
            "text": "High-Level Resistance"
          },
          {
            "drugClass": {
              "name": "NNRTI"
            },
            "drug": {
              "name": "NVP",
              "displayAbbr": "NVP"
            },
            "score": 155.0,
            "partialScores": [
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 30.0
              },
              {
                "mutations": [
                  {
                    "text": "Y181C",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 60.0
              },
              {
                "mutations": [
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 60.0
              },
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  },
                  {
                    "text": "Y181C",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 5.0
              }
            ],
            "text": "High-Level Resistance"
          },
          {
            "drugClass": {
              "name": "NNRTI"
            },
            "drug": {
              "name": "RPV",
              "displayAbbr": "RPV"
            },
            "score": 130.0,
            "partialScores": [
              {
                "mutations": [
                  {
                    "text": "K101E",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 45.0
              },
              {
                "mutations": [
                  {
                    "text": "Y181V",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181I/V are 2-base pair non-polymorphic mutations selected by NVP and ETR. They cause high-level resistance to NVP, ETR, and RPV. They each have a weight of 3.0 in the Tibotec ETR genotypic susceptibility score. Their effects on DOR have not been well-characterized."
                      }
                    ]
                  }
                ],
                "score": 60.0
              },
              {
                "mutations": [
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 15.0
              },
              {
                "mutations": [
                  {
                    "text": "Y181C",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
                      }
                    ]
                  },
                  {
                    "text": "G190A",
                    "primaryType": "NNRTI",
                    "comments": [
                      {
                        "type": "NNRTI",
                        "text": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
                      }
                    ]
                  }
                ],
                "score": 10.0
              }
            ],
            "text": "High-Level Resistance"
          }
        ]
      }
    ]
  }
]